Navigation Links
Cardiogenesis Reports First Quarter 2011 Results
Date:5/4/2011

IRVINE, Calif., May 4, 2011 /PRNewswire/ -- Cardiogenesis Corporation (OTCQB: CGCP), a leading developer of surgical products used in the treatment of diffuse coronary artery disease, today reported financial results for its first quarter ended March 31, 2011.

Revenue for the first quarter of 2011 was $3,053,000, a 6% decrease from prior year first quarter revenue of $3,233,000.  The company reported a net loss of $433,000, or $0.01 per basic and diluted share, in the first quarter of 2011 as compared with net loss of $18,000, or $0.00 per basic and diluted share, in the prior year first quarter.

"We posted a solid performance for the first quarter of 2011 with product revenues in excess of $3.0 million dollars. In addition, we completed our preclinical work at the Texas Heart Stem Cell Center which included bone marrow compatibility testing as well as a large animal safety study for the PHOENIX™ System," said Cardiogenesis Executive Chairman Paul McCormick. "On March 29th, we announced the signing of a definitive agreement to be acquired by CryoLife, Inc. in an all cash transaction valued at approximately $22 million.  The transaction is expected to close before the end of the second quarter."

Handpiece revenue for the first quarter of 2011 increased slightly to $2,235,000 as compared to $2,230,000 in the 2010 first quarter.  Laser revenue in the first quarter of 2011 totaled $540,000, a decrease of $174,000 from the first quarter of 2010.

Gross margin was 86% of net revenue for the first quarter of 2011, a two percentage point increase from the first quarter of 2010.  Gross profit decreased by $82,000, or 3%, to $2,623,000 for the first quarter of 2011 as compared with $2,705,000 for the 2010 first quarter.

Research and development expenses of $521,000 in the quarter ended March 31, 2011 increased $233,000, or 81%, compared with $288,000 in the quarter ended March 31, 2010.  

Sales and mar
'/>"/>

SOURCE Cardiogenesis Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. CryoLife Completes Tender Offer for 49.9 Percent of the Outstanding Shares of Cardiogenesis Corporation
2. Cardiogenesis Corporation to Report 2011 First Quarter Results on May 4th
3. CryoLife Announces Expiration of Go-Shop Period Related to its Proposed Acquisition of Cardiogenesis Corporation
4. CryoLife Commences Tender Offer for All Outstanding Shares of Cardiogenesis Corporation
5. CryoLife Signs Definitive Agreement to Acquire Cardiogenesis
6. Cardiogenesis Reports Fourth Quarter and Full Year 2010 Results
7. Cardiogenesis Corporation to Report 2010 Fourth Quarter and Full-Year Results on March 9th
8. Cardiogenesis Reports Third Quarter 2010 Results
9. Cardiogenesis Receives Research Award From Federal Government
10. Cardiogenesis Corporation to Report 2010 Third Quarter Results on November 3rd
11. Cardiogenesis Enrolls First Two Patients in Its Feasibility Study of the PHOENIX® Combination Delivery System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 23, 2015 /PRNewswire/-- Harwood Feffer LLP ( www.hfesq.com ) is ... Advaxis, Inc. ("Advaxis" or the "Company") (NASDAQ: ... fiduciary duties to shareholders. On January 21, ... reporting that Advaxis had misrepresented the clinical data for ...
(Date:1/23/2015)... Companies, Inc. (ICBU) has repositioned itself as a holding company ... foothold in the hydroponic, hemp and medical marijuana sectors. By ... the sector, and recently partnering with the Chippewa Tribe Nation ... marijuana, iMD is committing to bring its vision to the ...
(Date:1/23/2015)... MONMOUTH JUNCTION, N.J. , Jan. 23, 2015 ... immunotherapy company commercializing its CytoSorb® extracorporeal cytokine adsorber ... surgery patients, announced the receipt of $385,642, net ... approved participant of the Technology Business Tax Certificate ...
Breaking Medicine Technology:Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3
... (Nasdaq: YDNT ) today announced that it will ... on-demand web cast conference call on Thursday, October 21, 2010 ... the call will be available through InterCall at http://tinyurl.com/Quarter32010 ... available through the Company,s website, www.ydnt.com . ...
... one of the world,s largest and most sophisticated pharmacies ... (D-Nev.), today said innovative companies such as Medco Health ... bright future for a sustainable healthcare system for America ... Nevada by providing employment opportunities for skilled healthcare professionals. ...
Cached Medicine Technology:Young Innovations, Inc. Provides 3rd Quarter Conference Call Details 2Sen. Harry Reid to Medco Employees: Technology and Innovation Integral to Sustainable Healthcare Reform and Nevada's Future 2Sen. Harry Reid to Medco Employees: Technology and Innovation Integral to Sustainable Healthcare Reform and Nevada's Future 3
(Date:1/22/2015)... The U.S. Pharmacopeial Convention is pleased to announce that ... at North Carolina State’s College of Veterinary Medicine has ... for Distinguished Volunteer Service—the organization’s highest award. , ... volunteer experts to direct its work to improve the ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Woodloch Pines, an ... has been selected by TripAdvisor as the number one best ... 6th best in the world for their annual Travelers’ Choice ... travel community . The website is home to millions of ...
(Date:1/22/2015)... Houston, TX (PRWEB) January 22, 2015 The ... Pro Bodybuilder Ben Pakulski to increase lean muscle by up ... This has caught the attention of HealthyandFitZone.com’s Stan Stevenson, prompting ... shows that it is a step-by-step, scientific diet formula that ...
(Date:1/22/2015)... 2015 The federal court overseeing thousands of ... Court, Southern District of West Virginia has upheld a $2 ... first bellwether trial. In an Order dated January 21st, the ... finding that C.R. Bard had not proven a miscarriage of ...
(Date:1/22/2015)... 2015 Autocarinsurancebest.com has released a new blog ... auto insurance policy . , Auto insurance quotes help ... is no longer necessary to call an agent or visit ... online on a single website: http://autocarinsurancebest.com/ . , Every ...
Breaking Medicine News(10 mins):Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 2Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 3Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 4Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Commercial Auto Insurance Provides Several Important Features! 2
... US-based Redux Beverages said it would be marketing. Well, only it was ... drink. ,In September last year it announced the launch ... illegal drug. ,Jamey Kirby, the drink's inventor, said the name ... session at 1 o'clock in the morning. ,"It's an ...
... Cedars-Sinai Medical Center in Los Angeles have reported that they ... who had died and retransplanted it in another recipient. ... has been done with a transplanted heart, said Dr. Lawrence ... program. Even with other organs, repeat transplantation is very rare. ...
... nerve cells signal to one another could rewrite the textbooks ... Weill Cornell Medical College and Yale University. ,Their ... Science, suggests that a key cellular enzyme called dynamin 1 ... previously assumed. ,Dynamin has long been a focus ...
... Children's Research Hospital have discovered inherited variations in certain ... (ALL) susceptible to the toxic side effects caused by ... polymorphisms, occur in specific genes known to influence pharmacodynamics ... drug is needed to have its intended effect). ...
... blood pressure and additional risk factors for heart ... rather than two , if their current treatment ... pressure-lowering medication amlodipine, researchers reported at the American ... Care and Outcomes Research in Cardiovascular Disease and ...
... mother's love is something we all treasure.; Same is the case ... Delhi . ,She has something special planned for her ... wished to be with her mother on Sunday, which is now ... her spirits down. Last time when I was in Delhi, I ...
Cached Medicine News:Health News:'Cocaine' Turns 'Censored' and Remains 'energy Drink' 2Health News:'Cocaine' Turns 'Censored' and Remains 'energy Drink' 3Health News:Transplanted Heart Goes to a Second Recipient in a Rare Surgery 2Health News:Study Revises Dynamin's Role in Nerve Cell Function 2Health News:Study Revises Dynamin's Role in Nerve Cell Function 3Health News:Inherited Genes Linked to Toxicity of Leukemia Therapy 2Health News:One Pill may Be Better Than Two for Treating Patients With High Blood Pressure 2Health News:One Pill may Be Better Than Two for Treating Patients With High Blood Pressure 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: